Comorbidities frequently accompany chronic heart failure, contributing to increased morbidity and mortality, and an impaired quality of life. Extreme comorbidity is significantly more common in patients with chronic heart failure due to left ventricular systolic dysfunction. The efficient management of such complexity requires the integration of general and specialist expertise.
Heart Failure Comorbidities
Athena Adeli, Revathy Sampath-Kumar, Anne Wang, et al
Original Research
Michał Czapla, Christopher S Lee, Maria Jędrzejczyk, et al
Review Article
Daniel Escribano, Elena Díaz-Peláez, Victoria Delgado
Review Article
Ovidiu Chioncel, Alexandre Mebazaa, Sean P Collins, et al
Antonio Méndez-Durán, Juan B Ivey-Miranda, Genaro H Mendoza-Zavala, et al
Nikhil Ahluwalia, Shohreh Honarbakhsh, Ross Hunter, et al
Antonio Méndez-Durán, Juan B Ivey-Miranda, Genaro H Mendoza-Zavala, et al
Bahira Shahim, Chris J Kapelios, Gianluigi Savarese, et al
Video Series
Fausto J Pinto, John Spertus, , et al
Shubh K Patel, Hwee Teoh, Ahreni Saunthar, et al
Review Article
Daniel Escribano, Elena Díaz-Peláez, Victoria Delgado
Review Article
Ovidiu Chioncel, Alexandre Mebazaa, Sean P Collins, et al
About
Media
Video Series
Stefan Anker, Giuseppe Rosano, Javier de Juan Bagudá, et al
Robert Mentz, Harriette Van Spall
William T Abraham, Marianna Adamo, Stefan Anker , et al
James Burton, Shelley Zieroth, Clara Bonanad Lozano, et al
Media
Javed Butler, Dinesh Khullar, John JV McMurray, et al
Joe Carver, Osnat Itzhaki Ben Zadok, Jose Álvarez-Cardona
Video Series
HFSA 2025 Late-Breaking Science CollectionArticles
Aldosterone and Potassium in Heart Failure
Published:
20 December 2024
Citation:
Cardiac Failure Review 2024;10:e18.
- Abstract
- Full text
- Login or register to view PDF.
- Permissions
- References
-
For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.
For author reprints, please email rob.barclay@radcliffe-group.com.
- Downloads:
252
- Citations: 4
-
Read time: 37m 48s
RDW Prognostic Marker in HF and Predictor for Iron Replacement Responsivene
Published:
28 November 2024
Citation:
Cardiac Failure Review 2024;10:e17.
- Abstract
- Full text
- Login or register to view PDF.
- Permissions
- References
-
For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.
For author reprints, please email rob.barclay@radcliffe-group.com.
- Downloads:
67
- Citations: 10
-
Read time: 5m 59s
Risk Prediction of CVD in the Asia-Pacific Region
Published:
29 November 2024
Citation:
Journal of Asian Pacific Society of Cardiology 2024;3:e43.
- Abstract
- Full text
- Login or register to view PDF.
- Permissions
- References
-
For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.
For author reprints, please email rob.barclay@radcliffe-group.com.
- Downloads:
63
-
Read time: 19m 42s
Mineralocorticoid Receptor Antagonists in Heart Failure
Published:
12 November 2024
Citation:
Cardiac Failure Review 2024;10:e15.
- Abstract
- Full text
- Login or register to view PDF.
- Permissions
- References
-
For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.
For author reprints, please email rob.barclay@radcliffe-group.com.
- Downloads:
266
- Citations: 15
-
Read time: 19m 41s